These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18816769)

  • 21. Acute severe ulcerative colitis: Changing treatment paradigms.
    Lawrance IC
    J Gastroenterol Hepatol; 2016 Jun; 31 Suppl 1():16. PubMed ID: 26991023
    [No Abstract]   [Full Text] [Related]  

  • 22. Infliximab salvage therapy for patients with ulcerative colitis who failed to respond to tacrolimus.
    Tsukamoto H; Tanida S; Mizoshita T; Ozeki K; Ebi M; Shimura T; Mori Y; Kataoka H; Kamiya T; Joh T
    Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):714-8. PubMed ID: 23411870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inducing remission of ulcerative colitis: are clinicians better equipped than ever?
    Armuzzi A; Felice C
    Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):95-7. PubMed ID: 23363258
    [No Abstract]   [Full Text] [Related]  

  • 24. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T; Umegae S; Matsumoto K
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of mucosal healing in ulcerative colitis.
    Lichtenstein GR; Rutgeerts P
    Inflamm Bowel Dis; 2010 Feb; 16(2):338-46. PubMed ID: 19637362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to: infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: early and late outcome and predictors of colectomy.
    Tung J; Enders FT; Loftus EV
    J Crohns Colitis; 2014 Oct; 8(10):1327-8. PubMed ID: 24631323
    [No Abstract]   [Full Text] [Related]  

  • 27. New Zealand Society of Gastroenterology Guidelines for the Management of Refractory Ulcerative Colitis.
    Eliadou E; Day AS; Thompson-Fawcett MW; Gearry RB; Rowbotham DS; Walmsley R; Schultz M; Inns SJ; ;
    N Z Med J; 2015 Oct; 128(1423):63-76. PubMed ID: 26645757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. My treatment approach to the management of ulcerative colitis.
    Katz S
    Mayo Clin Proc; 2013 Aug; 88(8):841-53. PubMed ID: 23910410
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cornelia de Lange syndrome in association with ulcerative colitis: a case report.
    Papiamonis N; Koutroubakis IE
    J Crohns Colitis; 2013 Oct; 7(9):e399-400. PubMed ID: 23587783
    [No Abstract]   [Full Text] [Related]  

  • 30. Infliximab versus ciclosporin in severe ulcerative colitis.
    Levesque BG; Sandborn WJ
    Lancet; 2012 Dec; 380(9857):1887-8. PubMed ID: 23063315
    [No Abstract]   [Full Text] [Related]  

  • 31. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low colectomy rate five years after diagnosis of ulcerative colitis. Results from a prospective population-based cohort in Sweden (ICURE) diagnosed during 2005-2009.
    Rönnblom A; Holmström T; Tanghöj H; Karlbom U; Thörn M; Sjöberg D
    Scand J Gastroenterol; 2016 Nov; 51(11):1339-44. PubMed ID: 27356846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of a symbiotic product during clinical relapse of ulcerative colitis.
    Guslandi M
    J Clin Gastroenterol; 2011; 45(5):475-6. PubMed ID: 21336142
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment and recurrence prevention ulcerative colitis].
    Schölmerich J
    Internist (Berl); 1995 Dec; 36(12):1124-32. PubMed ID: 8567217
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids.
    Garcia-Planella E; Mañosa M; Van Domselaar M; Gordillo J; Zabana Y; Cabré E; López San Román A; Domènech E
    Dig Liver Dis; 2012 Mar; 44(3):206-10. PubMed ID: 22079262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2019 Feb; 156(3):765. PubMed ID: 30684448
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical therapy in ulcerative colitis].
    Motegi K; Nagasako K; Nogawa H; Akiya T; Kon Y; Sawada T
    Nihon Rinsho; 1999 Nov; 57(11):2466-71. PubMed ID: 10572413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent Sjögren's syndrome in a patient with ulcerative colitis during infliximab therapy: a rare association.
    Qanneta R; Papo M; Fontova R
    J Crohns Colitis; 2013 Sep; 7(8):e327-8. PubMed ID: 23380293
    [No Abstract]   [Full Text] [Related]  

  • 39. Differences in the management of pediatric and adult onset ulcerative colitis--lessons from the joint ECCO and ESPGHAN consensus guidelines for the management of pediatric ulcerative colitis.
    Ruemmele FM; Turner D
    J Crohns Colitis; 2014 Jan; 8(1):1-4. PubMed ID: 24230969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with adalimumab in anti-TNF-naïve patients with ulcerative colitis.
    Busquets D; Aldeguer X
    J Crohns Colitis; 2013 Jun; 7(5):e195. PubMed ID: 23219261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.